SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales declined to Rs. 11870.52 millions for the March 2024 quarter as compared to Rs. 12922.34 millions during the corresponding quarter last year.The Net Profit of the company registered a slight decline of -13.42% to Rs. 1825.97  millions from Rs. 2108.92 millions.Operating Profit reported a sharp decline to 2884.46 millions from 3348.52 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 11870.52 12922.34 -8.14 26026.67 33127.33 -21.43 26026.67 33127.33 -21.43
Other Income 549.31 579.22 -5.16 2707.86 1735.68 56.01 2707.86 1735.68 56.01
PBIDT 2884.46 3348.52 -13.86 4438.24 6632.36 -33.08 4438.24 6632.36 -33.08
Interest -1.96 21.82 -108.98 16.96 38.69 -56.16 16.96 38.69 -56.16
PBDT 2886.42 3326.70 -13.23 4421.28 6593.67 -32.95 4421.28 6593.67 -32.95
Depreciation 542.43 676.50 -19.82 2670.78 2480.65 7.66 2670.78 2480.65 7.66
PBT 2343.99 2650.20 -11.55 1750.50 4113.02 -57.44 1750.50 4113.02 -57.44
TAX 518.02 541.28 -4.30 382.86 865.59 -55.77 382.86 865.59 -55.77
Deferred Tax 226.29 11.13 1933.15 93.93 145.52 -35.45 93.93 145.52 -35.45
PAT 1825.97 2108.92 -13.42 1367.64 3247.43 -57.89 1367.64 3247.43 -57.89
Equity 902.20 902.20 0.00 902.20 902.20 0.00 902.20 902.20 0.00
PBIDTM(%) 24.30 25.91 -6.23 17.05 20.02 -14.83 17.05 20.02 -14.83

Sharda Cropchem Share Price

1109.70 9.05 (0.82%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 665.00
PI Industries 3144.45
Bayer CropScience 4900.45
Sharda Cropchem 1109.70
Sumitomo Chemical 441.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×